Detoxifying Cancer Causing Agents to Prevent Cancer

Integrative Cancer Therapies

Volumn 2, Issue 2, 2003, Pages 139-144

  Hanausek, Margaret ^a   Walaszek, Zbigniew ^a   Slaga, Thomas J ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Cancer prevention; Carcinogens; Detoxification; Natural products

Indexed keywords

1 ETHYNYLPYRENE; 3 INDOLEMETHANOL; ACETYLCYSTEINE; ALLYL SULFIDE; ALPHA NAPHTHOFLAVONE; ANTIESTROGEN; BETA GLUCURONIDASE; BUTYLATED HYDROXYANISOLE; BUTYLCRESOL; CARCINOGEN; COUMARIN; EFLORNITHINE; ELLAGIC ACID; EPIGALLOCATECHIN GALLATE; ETHOXYQUIN; GENISTEIN; GLUCURONOLACTONE; MUTAGENIC AGENT; NATURAL PRODUCT; OLTIPRAZ; PHENYL ISOTHIOCYANATE; QUERCETIN; RESVERATROL; SACCHARATE CALCIUM; SACCHARIC ACID; SELENIUM; TRACE ELEMENT; TUMOR PROMOTER; UNCLASSIFIED DRUG; UNINDEXED DRUG; VITAMIN;

ANTINEOPLASTIC ACTIVITY; CANCER PREVENTION; CANCER STAGING; CARCINOGENESIS; DETOXIFICATION; DRUG MECHANISM; FRUIT; PLANT PRODUCT; PRIORITY JOURNAL; REVIEW; SELF MEDICATION; VEGETABLE;

ANIMALS; ANTICARCINOGENIC AGENTS; ANTIOXIDANTS; BIOLOGICAL MARKERS; CHEMOPREVENTION; DIET; DIETARY SUPPLEMENTS; GLUCARIC ACID; GLUCURONIDASE; HUMANS; NEOPLASMS; NEOPLASMS, EXPERIMENTAL; PROGNOSIS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 0142179085     PISSN: 15347354     EISSN: None     Source Type: Journal    
DOI: 10.1177/1534735403002002005     Document Type: Review

References (31)

1. Wattenberg LW. Inhibition of carcinogenesis by minor dietary constituents. Cancer Res. 1992;52:2085s-2091s.
2. Hursting SD, Slaga TJ, Fischer SF, DiGiovanni J, Phang JM. Mechanism-based cancer prevention approaches: targets, examples, and the use of transgenic mice. J Natl Cancer Inst. 1999;91:215-225.
3. Dutton GJ. Glucuronidation of Drugs and Other Compounds. Boca Raton, Fla: CRC Press; 1980.
4. Burchell B, Coughtrie MHW. UDP-Glucuronosyltransferases. Pharm Ther. 1989;43:261-289.
5. Siest G, Magdalou J, Burchell B. Celhdar and Molecular Aspects of Glucuronidation. Paris: INSERM; 1988.
6. Reddy BS, Weisburger JH, Wynder EL. Fecal bacterial β-glucuronidase: control by diet. Science. 1974;183:416-417.
7. Levy G, Conchi J. β-Glucuronidase and the hydrolysis of glucuronides. In: Dutton GJ, ed. Glucuronic Acid: Free and Combined. New York: Academic Press; 1966:301-364.
8. Blumenthal HJ, Lucuta VL, Blumenthal DC. Specific enzymic assay for D-glucarate in human serum. Anal Biochem. 1990;185:286-293.
9. Colombi A, Maroni M, Antonini C, Fait A, Zocchetti C, Foa V. Influence of sex, age and smoking habits on the urinary excretion of D-glucaric acid. Clin Chim Acta. 1983;128:349-358.
10. Batt HM, Siest G. Laboratory tests as in direct indications of the activity of drug metabolizing enzymes: use of glucaric acid and gamma-glutamyltranspeptidase. Dev Clin Biochem. 1980;2:178-192.
11. Yokoyama M, Matsuoka S, Wakui A. Activation of tegafur and urinary excretion of D-glucaric acid in tumor-bearing hosts. In: Ishigami J, ed. Recent Adv Chemother, Proc Int Congr Chemother; 14th. Tokyo, Japan: University of Tokyo Press; 1985:113-115.
12. Walaszek Z. Potential use of D-glucaric acid derivatives in cancer prevention. Cancer Lett. 1990;54:1-8.
13. Walaszek Z. Chemopreventive properties of D-glucaric acid derivatives. Cancer Bull. 1993;45:453-457.
14. Yoshimi N, Walaszek Z, Mori H, Hanausek M, Szemraj J, Slaga TJ. Inhibition of azoxymethane-induced rat colon carcinogenesis by potassium hydrogen D-glucarate. Int J Oncol. 2000;16:43-48.
15. Walaszek Z, Szemraj J, Hanausek M, Adams AK, Sherman U. D-Glucaric acid content of various fruits and vegetables and cholesterol lowering effects of dietary D-glucarate in the rat. Nutr Res. 1996;16:673-682.
16. Brewster MA. Biomarkers of xenobiotics exposure. Ann Clin Lab Sci. 1988;18:306-317.
17. Walaszek Z, Hanausek M, Szemraj J, Adams AK. D-Glucaric acid as a prospective tumor marker. Methods Mol Med. 1998;14:487-495.
18. Walaszek Z, Raich P, Hanausek M, Szemraj J, Narog M, Slaga TJ. Potential role of D-glucaric acid in lung cancer prevention. Proc Am Assoc Cancer Res. 2002;43:306.
19. National Research Council; Committee on Diet and Health, Food and Nutrition Board; Commission on Life Sciences. Diet and Health: Implications for Reducing Chronic Disease Risk. Washington, DC: National Academy Press; 1989.
20. Food, Nutrition and the Prevention of Cancer: A Global Perspective. Washington, DC: World Cancer Research Fund/American Institute for Cancer Research; 1997.
21. Slaga TJ, O'Connell J, Rotstein J, et al. Critical genetic determinants and molecular events in multistage skin carcinogenesis. Symp Fundam Cancer Res. 1987;39:31-34.
22. DiGiovanni J. Multistage carcinogenesis in mouse skin. Pharmacol Ther. 1992;47:63-128.
23. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990;61:759-767.
24. Slaga TJ. Inhibition of skin tumor initiation, promotion, and progression by antioxidants and related compounds. Crit Rev Food Sci Nutr. 1995;35:51-57.
25. Marks F, Furstenberg G. Cancer chemoprevention through interruption of multistage carcinogenesis: the lessons learnt by comparing mouse skin carcinogenesis and human large bowel cancer. Eur J Cancer. 2000;36:314-329.
26. Bishop JM. Molecular themes in oncogenesis. Cell. 1991;64:235-248.
27. Marshall CJ. Tumor suppressor genes. Cell. 1991;64:313-326.
28. Hanausek M, Ganesh P, Walaszek Z, Slaga TJ, Arntzen C, Gutterman JU. Avicins, a family of triterpenoid saponins from Acacia victoriae (Bentham), suppress H-ras mutations and aneuploidy in a murine skin carcinogenesis model. Proc Natl Acad Sci U S A. 2001;98:11551-11556.
29. Mokbel K. The evolving role of aromatase inhibitors in breast cancer. Int J Clin Oncol. 2002;7:279-278.
30. Block KI, Gyllenhaal C. Clinical corner: herb-drug interaction in cancer chemotherapy: theoretical concerns regarding drug metabolizing enzymes. Int Cancer Ther. 2002;1:83-89.
31. Lippman SM, Hong WK. Cancer prevention science and practice. Cancer Res. 2002;62:5119-5125.